Background: The market landscape of the US global market for microRNA research tool, services, diagnostics and drug discovery is estimated to grow 13% annually and reach $1 billion in the next 4 years. The market continues to grow with many pharmaceutical and biotech companies becoming more and more involved in microRNA research to discover specific microRNA biomarkers for diagnostics and therapeutics. Current techniques are unable to identify which microRNA carriers are the most appropriate for disease diagnosis. In this regard, there are relationships between microRNA dysregulation and human disease in approximately 168 diseases, including cancers, heart disease, diabetes, alcoholism, and obesity. Brief Description: UCR researchers have developed methods for rapid separation of different microRNA carriers in serum, using asymmetrical flow field flow fractionation or specially designed microchips. They have successfully identified microRNAs carriers as sensitive biomarkers, which will aid in the discovery of more effective therapeutic approaches.